adplus-dvertising
Connect with us

Business

Coronavirus vaccine will arrive in Canada on Monday, government says – Global News

Published

 on


Coronavirus vaccine doses will arrive in Canada on Monday, Procurement Minister Anita Anand has confirmed.

“This has been a wonderful week for Canadians. We are going to have vaccines in this country on Monday,” Anand said, speaking in the House of Commons during question period on Monday.

Read more:
Canada approves Pfizer coronavirus vaccine, will start administering ‘within days’

While officials had said that vaccines arriving on Monday was a good possibility, no government voice had given firm confirmation that Dec. 14 would definitively be the day the newly approved Pfizer coronavirus vaccine would be arriving on Canadian soil.

Speaking on Wednesday, Maj.-Gen. Dany Fortin, who is leading Canada’s vaccine distribution plans, said the doses would ship from Belgium on Friday and could begin arriving on Monday or Tuesday.

Story continues below advertisement

“We expect vaccines to be shipped very soon – by the end of the week,” he said, adding that the final details would become clear as the shipping process gets underway.


Click to play video 'Coronavirus: Health Canada official outlines process for approving Pfizer vaccine'



2:08
Coronavirus: Health Canada official outlines process for approving Pfizer vaccine


Coronavirus: Health Canada official outlines process for approving Pfizer vaccine

It appears those details may have been clarified, given that Anand spoke firmly about the vaccine doses arriving on Monday. Her confirmation comes just one day after officials announced the vaccine’s approval for use in Canada.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Dr. Supriya Sharma, chief medical advisor with the regulatory branch of Health Canada, announced the news in a press conference on Wednesday. She said the approval marked a “momentous occasion.”

“It’s an exceptional day for Canada,” Sharma said.

“In a year where we haven’t had a lot of good news, this is a bit of good news. And I think we should take a moment to acknowledge that — and then we’re all going to get back to work.”

Story continues below advertisement

Since the approval, details about the vaccine’s distribution timeline have been trickling out. Ontario Premier Doug Ford confirmed on Thursday that health-care workers in Toronto and Ottawa would get the province’s first doses next Tuesday, while Alberta says it plans to distribute the doses starting next Wednesday.

Read more:
Coronavirus: Ottawa, Toronto to each receive 3,000 doses of Pfizer vaccine next week

The federal government has said that the plan is to roll out initial vaccine doses to four priority groups: residents and employees at long-term care homes, Canadians aged 70 and above, front-line health-care workers and adults in Indigenous communities.


Click to play video 'Coronavirus: BioNTech CFO on vaccine shipments, doses Canadians can expect'



7:46
Coronavirus: BioNTech CFO on vaccine shipments, doses Canadians can expect


Coronavirus: BioNTech CFO on vaccine shipments, doses Canadians can expect

The Public Health Agency of Canada added that the plan is to begin vaccinating the general population in April, with the goal of inoculating the entire country by the end of September.

Story continues below advertisement

“I mean, the geek in me is amazed. No one would have thought, even when we looked back at the first discovery of the virus, that less than a year later we’d be authorizing and then distributing a vaccine,” Sharma said on Wednesday.

Health officials have also stressed that while the approval process happened fast, it was as thorough as the process for any other drug that has been given the go-ahead for use in Canada.

Still, some questions remain about the vaccine. The Pfizer vaccine, which is the first and only vaccine to be approved for use in Canada to date, is not approved for use on those under the age of 16 – that’s just shy of 17 per cent of Canada’s population.


Click to play video 'Coronavirus: Trudeau praises Pfizer vaccine approval in House of Commons'



1:13
Coronavirus: Trudeau praises Pfizer vaccine approval in House of Commons


Coronavirus: Trudeau praises Pfizer vaccine approval in House of Commons

The next steps for immunizing those under the age of 16 are still unclear, as well as the plans for inoculating those who are allergic to the Pfizer vaccine’s ingredients.

Story continues below advertisement

The concern comes after two vaccine recipients in the U.K. had allergic reactions to the jab. While both had previous histories of significant allergic reactions, Health Canada is closely monitoring for any adverse reactions to the vaccine.

As it stands now, Sharma has said those with allergies to the vaccine’s active ingredient or any of the vaccine’s other ingredients “should not take it.”

Read more:
Pfizer’s coronavirus vaccine is not approved for Canadians under 16. Here’s why

Additionally, there is still more research required with respect to the longevity of the protection afforded by the newly approved vaccine – though Sharma said there are promising early findings in this area.

Canada is currently evaluating three other vaccine candidates from Moderna, AstraZeneca and Johnson & Johnson. The approval of any of these vaccines could speed up the timeline of Canada’s vaccination efforts.

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending